Sara Beygi

Three-year follow-up analysis of axicabtagene ciloleucel in relapsed/refractory indolent non-Hodgkin lymphoma (ZUMA-5)

Sattva S. Neelapu, Julio C. Chávez, Alison R. Sehgal et al. · Blood · 2023 · 141 citations · Full text

Medicine, Oncology, Pharmacology +16

Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas

Brian J. Sworder, David M. Kurtz, Stefan Alig et al. · Cancer Cell · 2022 · 133 citations · Full text

Life Sciences, Immunology, Oncology +13

Patients with psoriasis are at a higher risk of developing nonalcoholic fatty liver disease

Robabeh Abedini, Mohammad Salehi, Vahide Lajevardi et al. · Clinical and Experimental Dermatology · 2015 · 85 citations

Medicine, Dermatology, Autoimmunity +13

Timing in the surgical evacuation of spinal epidural abscesses

George M. Ghobrial, Sara Beygi, Matthew J. Viereck et al. · Neurosurgical FOCUS · 2014 · 65 citations · Full text

Medicine, Neurosurgery, Surgery +15

CD20-Targeted Therapy Ablates <i>De Novo</i> Antibody Response to Vaccination but Spares Preestablished Immunity

Tanaya Shree, Vishnu Shankar, Julian J.K. Lohmeyer et al. · Blood Cancer Discovery · 2022 · 48 citations · Full text

Medicine, Immunology, Oncology +17